Covid-19 Update

David Johnston Excerpts

Monday 17th May 2021 Commons Chamber

[Matt Hancock]

I am afraid I do not agree with the hon. Lady’s characterisation of the situation, not least because the approach we are taking in Bolton did work effectively in south London. We are piloting new approaches to ensuring that we can support people to isolate, and some of those pilots are taking place in areas where we can see cases of B1617.2. We keep this under close scrutiny and review to see what works effectively.

[David Johnston (Wantage) (Con)]

Part of our fight against covid, and indeed against future viruses, is to improve our domestic vaccine manufacturing capability. To that end, the Government are fast-tracking the Vaccines Manufacturing and Innovation Centre at Harwell in my constituency. I will be visiting it in a few weeks, but could my right hon. Friend provide an update on the progress so far?

[Matt Hancock]

Yes, we are making significant progress with the onshoring of vaccine capability. It is about developing the vaccine, as the team in Oxford did brilliantly, but also about manufacturing it onshore, and boy, if there is one lesson we have learned from this whole thing, it is that we cannot just not care about where manufacturing happens. Having it onshore really, really matters, for resilience but also to ensure that it is close to the NHS so that the whole supply chain can learn and constantly improve. I am delighted that we are pushing forward with the VMIC project in the same way that we have brought onshore manufacturing supply in Teesside, in Livingston in Scotland and in the fill-and-finish plants at Wockhardt in Wrexham, at Barnard Castle and elsewhere. It is a big project and, frankly, a big opportunity for life sciences in the UK to ensure that we can do all this onshore, because in my view, the pandemic has shown that we need to.